Jianke, a Guangzhou, China-based online B2C pharmacy and healthcare services platform, closed a US$130m Series B financing.
The round was led by GTJA Investment Group, with participation from HBM Healthcare Investments and Crescent Point.
The company intends to use the funds to continue to expand its business reach.
Founded in 2006 by Fangmin Xie, Chief Executive Officer, Jianke is an online B2C pharmacy in China, offering 680,000 SKUs and a set of healthcare advisory services, and having cumulatively served over 100 million customers.
The company now holds the full set of B2B and B2C pharmaceutical distribution licenses (A+B+C) and has already formed strategic partnerships with healthcare sector leaders such as Abbott and Gilead Sciences.
FinSMEs
04/09/2018